The Association between Use of Benzodiazepine Receptor Agonists and the Risk of Obstructive Sleep Apnea: A Nationwide...

Area of Science:

• Sleep Medicine
• Pharmacology
• Respiratory Medicine

Background:

• Obstructive sleep apnea (OSA) involves recurrent upper airway collapse during sleep.
• Benzodiazepine receptor agonists (BZRAs) can cause pharyngeal muscle relaxation, potentially worsening OSA.
• Understanding the link between BZRA use and OSA risk is crucial for patient safety.

Purpose of the Study:

• To investigate the association between Benzodiazepine receptor agonist (BZRA) use and the risk of developing obstructive sleep apnea (OSA).
• To analyze how usage patterns, dosage, duration, and drug class influence this association.

Main Methods:

• Utilized data from Taiwan's National Health Insurance Database (2002-2011).
• Included new BZRA users, identifying 1848 OSA cases and 1848 matched controls.
• Employed logistic regression to assess the relationship between BZRA exposure and OSA development.

Main Results:

• Current and recent past BZRA users exhibited an increased risk of OSA compared to distant past users.
• Higher cumulative BZRA doses correlated with a greater likelihood of developing OSA.
• Z-drug users demonstrated a reduced OSA risk relative to benzodiazepine users.

Conclusions:

• BZRA use is associated with an elevated risk of obstructive sleep apnea (OSA).
• The risk is more pronounced in current users and those with higher cumulative BZRA doses.
• Pharmacokinetic class matters, with Z-drugs offering a potentially lower risk profile than benzodiazepines for OSA development.